Research published Sunday evaluates the effectiveness of the active ingredient in injectable diabetes and obesity drugs when taken orally. By Dani Blum Reporting from the American Diabetes Association ...

(Yicai) Nov. 27 -- A diabetes medication developed by Tonghua Dongbao Pharmaceutical and jointly promoted by the Chinese drugmaker and its partner Sinovac Biotech has received regulatory approval for ...

Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard ...

(NewsNation) — An estimated 15.5 million U.S. adults have used injectable diabetes medicines like Ozempic and Wegovy to lose weight, according to a Gallup poll released Tuesday. The nationwide survey ...

Ozempic, a once-weekly injectable approved by the US Food and Drug Administration in 2017 for type 2 diabetes, has become a ...

Ozempic, Wegovy and other GLP-1 medications have gained widespread popularity for weight loss and diabetes control in recent years — but the spike in demand has made it difficult for some people to ...

WASHINGTON (AP) — The Food and Drug Administration has approved a new injectable diabetes drug from Eli Lilly and Co. for adults with the most common form of the disease. The agency on Thursday ...

Ads for the latest drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people — especially those with Type 2 diabetes, ...